Identifying sensitive measures of cognitive decline at different clinical stages of Alzheimer’s disease

OBJECTIVE: Alzheimer’s disease (AD) studies are increasingly targeting earlier (pre)clinical populations, in which the expected degree of observable cognitive decline over a certain time-interval is reduced as compared to the dementia stage. Consequently, endpoints to capture early cognitive changes...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Int Neuropsychol Soc
Main Authors: Jutten, Roos J., Sikkes, Sietske A.M., Amariglio, Rebecca E., Buckley, Rachel F., Properzi, Michael J., Marshall, Gad A., Rentz, Dorene M., Johnson, Keith A., Teunissen, Charlotte E., Van Berckel, Bart N.M., Van der Flier, Wiesje M., Scheltens, Philip, Sperling, Reisa A., Papp, Kathryn V.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8041916/
https://ncbi.nlm.nih.gov/pubmed/33046162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/S1355617720000934
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados